Abiopharma

🔍 VANDERPLOEG MARTIN J. (Director)

Company: WORKIVA INC (WK)

Report Date: 2026-08-18

Detailed Transactions and Holdings:

• Sold 2,780 shares of Class A Common Stock (Direct)
  Date: 2026-08-18 | Code: G | equity_swap_involved: 0 | shares_owned_after: 437,105.00 | transaction_form_type: 4
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-18 | Code: H | shares_owned_after: 292,275.00
• Holds 1,201,832 shares of Class B Common Stock (Derivative)
  Date: 2026-08-18 | Code: H | shares_owned_after: 1,201,832.00 | Footnotes: F1, F1, F1, F1
• Holds 200,204 shares of Employee Stock Option to Purchase Class A Common Stock at $12.4 per share (Derivative)
  Date: 2026-08-18 | Code: H | Expires: 2027-01-31 | Exercise: 2018-02-01 | shares_owned_after: 200,204.00 | Footnotes: F2, F3

Footnotes:

• F1: Each share of Class B Common Stock is convertible, at any time at the election of the holder, into one share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon (i) the date specified by the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, (ii) any transfer, except for certain "qualified transfers" (as defined in the Issuer's Certificate of Incorporation) or (iii) upon the death of a natural person holding shares of Class B Common Stock (subject to certain exceptions as defined in the Issuer's Certificate of Incorporation).
• F2: Grant of stock option pursuant to the Workiva Inc. 2014 Equity Incentive Plan.
• F3: Vests in three equal annual installments commencing on the first anniversary of the grant date.